Back
Mackenzie Emerging Markets Equity Index ETF Vs. Aligos Therapeutics Industry Stock Comparison
Buy
74
QEE.TO
Mackenzie Emerging Markets Equity Index ETF
Last Price:
$104.70
Seasonality Move:
-1.1%
Buy
56
ALGS
Aligos Therapeutics
Last Price:
$8.42
Seasonality Move:
-21.57%
Buy
74
Mackenzie Emerging Markets Equity Index ETF (QEE.TO)
is a Buy
Is Mackenzie Emerging Markets Equity Index ETF a Buy, Sell or Hold?
-
The current Mackenzie Emerging Markets Equity Index ETF [QEE.TO] share price is $104.57. The Score for QEE.TO is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
QEE.TO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $8.36. The Score for ALGS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QEE.TO Stock Price Chart
What is Mackenzie Emerging Markets Equity Index ETF's stock price today?
-
The Mackenzie Emerging Markets Equity Index ETF share price today is $104.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QEE.TO is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $8.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.
QEE.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 23.28 | Buy |
Relative Strength Index (14 RSI): | 62.24 | Buy |
Chaikin Money Flow: | 48 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (101.66 - 104.56) | Buy |
Bollinger Bands (100): | (95.03 - 103.13) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.44 | Buy |
Relative Strength Index (14 RSI): | 58.37 | Buy |
Chaikin Money Flow: | -40144 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.07 - 8.25) | Buy |
Bollinger Bands (100): | (4.27 - 12.63) | Sell |
QEE.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 104.58 | Sell |
20-day SMA: | 103.31 | Buy |
50-day SMA: | 101.44 | Buy |
200-day SMA: | 97.98 | Buy |
8-day EMA: | 66.36 | Buy |
20-day EMA: | 34.53 | Buy |
50-day EMA: | 15.48 | Buy |
200-day EMA: | 4.1 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.01 | Buy |
20-day SMA: | 7.8 | Buy |
50-day SMA: | 6.59 | Buy |
200-day SMA: | 15.18 | Sell |
8-day EMA: | 8.14 | Buy |
20-day EMA: | 7.7 | Buy |
50-day EMA: | 7.62 | Buy |
200-day EMA: | 12.89 | Sell |
Mackenzie Emerging Markets Equity Index ETF Earnings Growth & QEE.TO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.07 per share, an increase this year of $3.67 per share, and a decrease next year of $1.69 per share.
Mackenzie Emerging Markets Equity Index ETF Technical Analysis
Jun 27 | Jun 30 | Jul 2 | Jul 3 | Jul 4 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |